Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000478920 | SCV000568770 | pathogenic | not provided | 2016-04-15 | criteria provided, single submitter | clinical testing | The c.1083_1084dupCT pathogenic variant has been reported in multiple unrelated individuals with congenital myasthenia syndromes and in each report was observed in the heterozygous state along with the N88K pathogenic variant (Richard et al., 2003; Ioos et al., 2004; Das et al., 2014). This variant causes a frameshift starting with codon Tyrosine 362, changes this amino acid to a Serine residue and creates a premature Stop codon at position 10 of the new reading frame, denoted p.Tyr362SerfsX10. This variant is predicted to cause loss of normal protein function through protein truncation. The c.1083_1084dupCT variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.1083_1084dupCT as a pathogenic variant. |
OMIM | RCV000170473 | SCV000222901 | pathogenic | Congenital myasthenic syndrome 11 | 2014-11-01 | no assertion criteria provided | literature only | |
Natera, |
RCV001826868 | SCV002087296 | pathogenic | Congenital myasthenic syndrome | 2021-05-14 | no assertion criteria provided | clinical testing |